Currently, twenty companies are tenants at FIZ and provide around 800 jobs. The infrastructure of the campus with its shared services allows for flexible work, customized to the companies' individual needs. In addition, tenants also benefit from the collaboration, the interdisciplinary networks, and the access to new markets that FIZ provides.
bio.logis digital health GmbH is a digital genomics company starting as a spin-off from a genetic diagnostic laboratory setting. Our goal is to develop smart applications and functionalities to drive the implementation of genetic data into clinical decision-making.
For laboratories and hospitals, the company provides highly innovative software solutions enabling automated interpretation, diagnostic reporting & delivery of genetic data. This supports patients and physicians at point of care in making informed decisions based on information derived from DNA.
The bio.logis team consists of experienced human geneticists, scientists and IT experts.
Building software solutions for complex medical tasks requires excellent software development expertise and a deep understanding of medical decision-making processes.
Cyntegrity is one of the leading risk-based quality management technology providers in the BioPharma industry. We're proud of our bespoke and highly rated MyRBQM® Portal and MyRBQM® Academy brands.
We support sponsors and CROs with clinical trial risk management technology and related educational programs to focus monitoring resources on the locations and activities where they are most needed.
Cyntegrity is a fast-growing scale-up company staffed by an international team of industry experts. We strive to become the first-choice provider of fit-for-purpose cloud and SaaS solutions for ICH GCP E6 and E8 compliant risk-based quality management and clinical research.
Diagnosticum Center for Human Genetics is an outpatient clinical institute. It was initially called “bio.logis Center for Human Genetics” and founded by the specialist in human genetics, Prof. Dr. med. Daniela Steinberger in August 2009. Since then, the center has participated in medical care with a wide range of genetic diagnostics and counseling.
The center's team consists of experienced doctors, scientists and technical staff. The center has been a partner in Diagnosticum since July 2017. The Diagnosticum is a partnership network of doctors for laboratory medicine, pathology, microbiology and human genetics. Medical diagnostics from these medical fields are carried out on behalf of doctors from the outpatient and inpatient sectors.
Prof. Dr. Daniela Steinberger
Fast Forward Discoveries - FFX provides cutting-edge technologies for enzyme-free tissue dissociation and high throughput single-cell analysis - enabling breakthrough innovations in cytological analytics, medical diagnostics and cell-based therapeutics.
MBN Research Center gGmbH develops and distributes the state-of-the-art software for advanced research and computational multiscale modelling of complex Meso-Bio-Nano systems. The software has many unique features and a broad range of applications in Physics, Chemistry, Biology, Materials Science, and industries.
The Center carries out a broad programme of frontier research based on the utilisation of its software, participates in collaborative research projects, organises thematic conferences, hands-on tutorials and training courses in different areas of academic and industrial research.
Prof. Dr. Andrey Solov’yov
Merz Pharma GmbH & Co. KgaA is involved in the research of metabolic, neurological, and psychiatric diseases and supplies drugs for treatment of Alzheimer's disease and other neurological and dermatological diseases.
Octapharma is the largest privately owned plasma manufacturer world-wide. We produce products for immune therapy, hematology and intensive care. Octapharma has always been a pioneer in viral safety; notably being the first company to implement solvent detergent (S/D) treatment in a FVIII product in the 1980s. Over the years Octapharma has put focus on pathogen safety. At Frankfurter Innovation Center (FiZ) two key departments of Octapharma’s Safety Strategy are situated: Molecular Diagnostics provides PCR testing services in a GMP regulated environment as well as related scientific support for the whole Octapharma group. As demanded by relevant pharmacopoeias, our goal is to ensure that all source material used for production of life saving pharmaceuticals is free of detectable Hepatitis- and Human Immunodeficiency Viruses. Virus and Prion Validation department is responsible for a wide spectrum of virus and prion safety activities. One important aspect of our work is the proof that no contamination with pathogens like viruses or prions puts the patients in danger to get infected by the therapeutic product. In this regard, we perform laboratory studies with validated downscale models of production processes to evaluate their capacity to remove or inactivate pathogens.
Perspix Biotech is radically changing the development of biotherapeutics of the next generation by combining end-to-end automated lab operations with AI powered protein engineering. The Perspix Platform allows for the development and optimization of novel biopharmaceutical drug candidates in months instead of years.
With current standard methodologies, optimization of a single drug candidate usually takes years along with very low success rates. Perspix is using ultra high-throughput and digitally enabled engineering solutions to develop next-generation drug candidates. In the process, massive data sets are created and are used to train Perspix’s AI core. It is this combination of in-silico solutions with fully automated wet lab processes which leads to heavily increased efficiencies, and which delivers substantial reductions in development cost and time.
Perspix’s vision is to make cost-effective biomedicines a reality and to improve the treatment outcomes for millions of patients.
Dr. José Airas
The British company Proteome Sciences R&D is involved in proteome research and is concerned with the identification of protein biomarkers and target proteins for certain diseases.
SIGNALS is a young company providing LOGS, a software platform for the digitization of laboratory research data, metadata and related workflows.
LOGS stores data automatically from instruments, giving lab scientists and other lab software (e.g. LIMS & ELNs) a centralized and powerful data repository to draw from.
Dr. Jakob J.Lopez
Sri Sri Tattva, founded under the inspiration of Gurudev Sri Sri Ravi Shankar, promotes holistic approach to health and wellness through a College of Ayurveda Science and Research, a state of the art Hospital, Panchakarma Wellness Centers and technology driven Manufacturing facilities with stringent quality controls.
We are a global conglomerate offering products and services across multiple categories like Ayurveda Supplements, Hygiene, Food, Personal Care and Home Care.
The groundbreaking ceremony for FiZ was held in 2002. One thing above all was seen at Frankfurt Riedberg: a great deal of free space. The first construction phase of FiZ was started in 2004, followed by the second construction phase in 2008, and six years later by the third construction phase at Altenhöferallee 5. Riedberg has meanwhile grown so much that 16,000 people live here and nearly 3000 come to work.
The Max Planck Institute for Brain Research, the scientific faculties of the Goethe University, and the Frankfurt Institute of Advanced Studies are located in the immediate vicinity of FIZ. (see enclosed PowerPoint files, other high-resolution file formats are available).
Details as per § 5 TMG
Operator and contact details
FiZ Frankfurter Innovationszentrum Biotechnologie GmbH
60438 Frankfurt am Main GERMANY
Phone: +49 (0) 69 800 865-0
Fax: +49 (0)69 800 865 19
Email: info( at )fiz-biotech.de
FiZ Frankfurter Innovationszentrum Biotechnologie GmbH is represented by
Dr. Christian Garbe
Registry and registry number: Frankfurt am Main HRB 55518
VAT ID no.:
Publication details on this website created using the generator of the Deutsche Anwaltshotline AG